Stability Challenges III: Assuring the stability of medicines from manufacture to use

12 October 2017 10:00-16:30, London, United Kingdom


Introduction
Continuing our successful Stability Challenges series, this is an essential event for anyone concerned with the management and assessment of drug stability:
• Hear from individuals involved in the regulation and inspection of stability and GDP
• Learn from industry experts on scientific developments in stability study design and interpretation
• Debate practical issues for clinical trials and amorphous drug formulations
• Examine ways to improve compliance and productivity in stability testing
• Network with other professionals and exhibitors

You will leave this event with:
• Best practice and case studies from regulatory and industry experts
• Understanding of key developments, issues and strategies in drug stability
• Improve your stability laboratory compliance and efficiency
• New connections to experts and opinion leaders in this field
• Assure the stability of your medicines
Speakers
  • Nigel McSweeney, Cuspor, Ireland
  • Dr Niels Hartvig Novo Nordisk, United Kingdom
  • Liselotte Kamper Novo Nordisk, United Kingdom
  • Dr Garry Scrivens, Pfizer, United Kingdom
  • Dr Samuel Kyeremateng NCE Formulation Sciences, AbbVie Deutschland GmbH, Germany
  • Dr Kristin Lehmkemper, NCE Formulation Sciences, AbbVie Deutschland GmbH, Germany

Sponsorship & supporting organisations
Royal Pharmaceutical Society and Royal Society of Chemistry
Venue
The Royal Society of Chemistry

The Royal Society of Chemistry, Burlington House, Piccadilly, London, W1J 0BA, United Kingdom

Organised by
JPAG
Contact information
Search
 
 
Showing all upcoming events
Start Date
End Date
Location
Subject area
Event type

Advertisement Spotlight Advertisement

E-mail Enquiry
*
*
*
*